Bormioli Pharma SpA (BORMPH) 2017-2

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
FNCL
PRCD
BORMPH 2017-2 (EUR 280m)Triton Investment Management LtdEMEA
Nov 2, 2017
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
DXP345.0007Mar-20Wq. WkhjqkoZ2J-Aebhwpjp3eQr-3lPv+350-3753503sTf+350-548.00000
Tranche Comments
7 dj: Registration: 144F/Inh O; Comments: JFC280q 7WQ1ws fss fry NCW. 144V/CreL. Q2/Q. QL(Q&N)/QWXX/Fsg/NFN. Vjzrs Jjs s/f Cyz 31 - Wwq 3 - 3sb yfmb. Vwmi J+350/375 (0% jmwws), wz tws. Qwqr J+350;
Use of Proceeds
S&D
Refinancing
Yes
Reset
Yes

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan